The Lowell P. Weicker, Jr.
Clinical Research Center (CRC) Seminar Series
On Methods in Clinical Research
Provided by
University of Connecticut School of Medicine
Office of Community and Continuing Medical Education and the Clinical Research Center
“Mucosal Toxicity Caused By Cancer Therapeutics”
Douglas E. Peterson, DMD, PhD, FDS RCSEd
Professor, Oral Medicine
Department of Oral Health and Diagnostic Sciences
School of Dental Medicine
Co-Chair, Program in Head & Neck Cancer/Oral Oncology
Neag Comprehensive Cancer Center
University of Connecticut Health Center
Farmington, CT
Date: Tuesday, October 7, 2014
Time: 12:00 Noon – 1:00 P.M.
Location: Low Learning Center – UCHC, Farmington, CT
On Demand: http://mediasite.uchc.edu/mediasite41/Play/bce6e30d31a347bebe23ab7131e114581d
Light lunch and beverage provided
Target Audience: Faculty, staff, residents, and students interested in clinical research
Learning Objectives: Participants will be able to: a) describe key molecular mechanisms associated with mucosal toxicity caused by cancer therapies; b) be familiar with selected clinical practice guidelines that have emerged in recent years based on laboratory- and clinically-based research; c) describe opportunities for future research and oncology patient care based on the continued evolution of the field.
Accreditation: The University of Connecticut School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Connecticut School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Conflict of Interest Policy: All faculty members participating in CME activities provided by the University of Connecticut School of Medicine are required to disclose to the program audience any actual or apparent conflict of interest related to the content of their presentations. Program planners have an obligation to resolve any actual conflicts of interest and share with the audience any safeguards put in place to prevent commercial bias from influencing the content.
Neither the activity director, planning committee members, nor the speaker, Dr. Peterson, has a financial interest/arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation.
Dr. Peterson will be discussing an off-label use of intestinal trefoil factor (ITF).
This CME activity has no commercial support associated with it. Food and refreshments provided by the CRC.
For more information, contact: Lisa Godin at Godin@uchc.edu